Development of an (123)I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease

OBJECTIVE(S): We recently developed a new uptake index method for (123)I-metaiodobenzylguanidine ((123)I-MIBG) heart uptake measurements by using planar images (radioisotope angiography and planar image) for the diagnosis of Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamiya, Yoshito, Ota, Satoru, Tanaka, Yuta, Yamashita, Kosuke, Takaki, Akihiro, Ito, Shigeki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038978/
https://www.ncbi.nlm.nih.gov/pubmed/29998146
http://dx.doi.org/10.22038/aojnmb.2018.10595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038978/
https://www.ncbi.nlm.nih.gov/pubmed/29998146
http://dx.doi.org/10.22038/aojnmb.2018.10595

Ejemplares similares